The 'Indirect' effects of cytomegalovirus infection: Minireview

American Journal of Transplantation

Volumn 9, Issue 11, 2009, Pages 2453-2458

  Freeman Jr , R B ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus (CMV); Cytomegalovirus infection; Immune modulation

Indexed keywords

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SHORT SURVEY;

CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNE SYSTEM; IMMUNOCOMPROMISED HOST; TRANSPLANTATION IMMUNOLOGY;

EID: 70350129075     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02824.x     Document Type: Short Survey

References (65)

1. Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 2006 259 : 219 246.
2. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991 72 (Pt 9 2059 2064.
3. Dunn W, Chou C, Li H et al. Functional profiling of a human cytomegalovirus genome. Proc Nat Acad Sci USA 2003 100 : 14223 14228.
4. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998 : 338 : 1741.
5. Paya CP, Pescovitz MH, Blumberg E et al. Efficacy and safety of once-daily oral valganciclovir vs oral ganciclovir three times daily for the prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 4 : 611 620.
6. Falagas ME, Snydman DR, Griffith J, and the Boston Center for Liver Transplantation CMVIG Study Group. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 1996 23 : 468 474.
7. Chopra KB, Demetris AJ, Blakolmer K et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003 76 : 1487 1491.
8. Razonable RR, Rivero A, Rodriguez A et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001 184 : 1461 1464.
9. Sagedal S, Nordal KP, Hartmann A et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002 2 : 850 856.
10. Sagedal S, Hartmann A, Nordal KP et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004 66 : 329 337.
11. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007 19 : 577 582.
12. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989 261 : 3561 3566.
13. Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 2002 74 : 576 578.
14. Speir E, Modali R, Huang ES et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994 265 : 391 394.
15. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993 14 (Suppl. K 30 38.
16. Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 2003 170 : 998 1002.
17. Harkins L, Volk AL, Samanta M et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002 360 : 1557 1563.
18. Hjelmesaeth J, Sagedal S, Hartmann A et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004 47 : 1550 1556.
19. Van Der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diab Metab Res Rev 2007 23 : 169 183.
20. Kim WR, Badley AD, Wiesner RH et al. The economic impact of cytomegalovirus infection after liver transplantation. Transplantation 2000 69 : 357 361.
21. Falagas ME, Arbo M, Ruthazer R et al. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. Transplantation 1997 63 : 1595 1601.
22. Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial. Am J Transplant 2008 8 : 975 983.
23. Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation 2009 87 : 436 444.
24. Dmitrienko S, Balshaw R, Machnicki G, Shapiro RJ, Keown PA. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines. Transplantation 2009 87 : 570 577.
25. Looney RJ, Falsey A, Campbell D et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999 90 : 213 219.
26. Fletcher JM, Prentice HG, Grundy JE. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J Immunol 1998 161 : 2365 2374.
27. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997 386 : 514 517.
28. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 1996 93 : 10990 10995.
29. Schrier RD, Rice GP, Oldstone MB. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis 1986 153 : 1084 1091.
30. Sester U, Presser D, Dirks J, Gartner BC, Kohler H, Sester M. PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant 2008 8 : 1486 1497.
31. Rahman AA, Teschner M, Sethi KK, Brandis H. Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol 1976 117 : 253 258.
32. Atalay R, Zimmermann A, Wagner M et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002 76 : 8596 8608.
33. Spiller OB, Hanna SM, Devine DV, Tufaro F. Neutralization of cytomegalovirus virions: The role of complement. J Infect Dis 1997 176 : 339 347.
34. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993 72 : 415 425.
35. Frascaroli G, Varani S, Blankenhorn N et al. Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J Immunol 2009 182 : 477 488.
36. Hodson EM, Craig JC, Strippoli GF, Webster AC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2008 : CD003774.
37. Snydman DR. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev Med Virol 2006 16 : 289 295.
38. Bentz GL, Yurochko AD. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci USA 2008 105 : 5531 5536.
39. Jarvis MA, Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 2002 5 : 403 407.
40. Stein J, Volk HD, Liebenthal C, Kruger DH, Prosch S. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer(promoter in immature monocytic cells. J Gen Virol 1993 74 (Pt 11 2333 2338.
41. Prosch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk KDH. Stimulation of the human cytomegalovirus IE enhancer (promoter in HL-60 cells by TNF-a is mediated via induction of NF-kB. Virology 1995 208 : 197 206.
42. Hummel M, Kurian SM, Lin S et al. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model. Transplantation 2009 87 : 178 188.
43. Asadullah K, Prosch S, Audring H et al. A high prevalence of cytomegalovirus antigenemia in patients with moderate to severe chronic plaque psoriasis: An association with systemic tumor necrosis factor alpha overexpression. Br J Dermatol 1999 141 : 94 102.
44. Prosch S, Wendt CE, Renke P et al. A novel link between stress and human cytomegalovirus infection; sympathetic hyperactivity stimulates HCMV activation. Virology 2000 272 : 357 365.
45. Lemstrom K, Shivola R, Bruggeman C, Hayry P, Koshinen P. Cytomegalovirus infection-enhanced cardiac allography vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 1997 95 : 2614 2616.
46. Burns LJ, Pooley JC, Walsh DJ, Webber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation 1999 67 : 137 144.
47. Sedmak DD, Knoght DA, Vook NC, Waldman JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on endothelial-infected cells. Transplantation 1994 58 : 1379 1385.
48. Craigen JL Yong KL, Jordan NJ et al. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 1997 92 : 138 145.
49. Speir E, Modali R, Huang ES et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994 265 : 391 394.
50. Hjelmesæth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997 64 : 979.
51. Hjelmesæth J, Sagedal S, Hartmann A et al. Asymptomatic CMV infection is associated with increased risk of new onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004 47 : 1500.
52. Hjelmesæth J, Jenssen T, Hagen M et al. Determinants of insulin secretion after renal transplantation. Metabolism 2003 52 : 573.
53. Valderhaug TG, Hjelmesaeth J, Rollag H et al. Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation 2007 84 : 1125 1130.
54. Boldogh L, AbuBakar S, Albrect T. Activation of protooncogenes: An immediate early event in human cytomegalovirus infection. Science 1990 247 : 561 564.
55. Harkins L, Volk AL, Samanta M et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002 360 : 1557 1563.
56. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991 65 : 6581 6588.
57. Jarvis MA, Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 2002 5 : 403 407.
58. Spencer JV, Lockridge KM, Barry PA et al. Potent immunosuppressive activites of cytomegalovirus-encoded interleukin-10. J Virol 2002 76 : 1285 1292.
59. Chan WL, Baumgarth N, Yu D, Barry PA. Human cytomegalovirus-encoded interleukin-10 homologue inhibits maturation of dendritic cell and alters their functionality. J Virol 2004 78 : 8720 8731.
60. Lilley BN, Ploegh HL, Tirabassi RS. Human cytomegalovirus open reading frame TRL11(IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 2001 75 : 11218 11221.
61. Atalay R, Zimmermann A, Wagner M et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002 76 : 8596 8608.
62. Penfold ME, Dairaghi DJ, Duke GM et al. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 1999 96 : 9839 9844.
63. Margulies BJ, Browne H, Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 1996 225 : 111 125.
64. Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional beta hemokine receptor. J Biol Chem 1994 269 : 28539 28542.
65. Kuhn DE, Beall CJ, Kolattukudy PE. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 1995 211 : 325 330.